Supplements · Sweeteners · Diets · Metabolic & Cardiometabolic
non-nutritive sweeteners causes cardiometabolic harm
In plain terms: Do artificial sweeteners harm your heart and metabolism?
Part of: • non-nutritive sweeteners
Probably not — the scary signal is likely backwards, and swapping sugar for them looks neutral in trials.
🧭 Read this score with how it was built in mindStudies we had treated as independent turned out to share a research group
Four sources filed under separate labels trace to the same Toronto research group, which also carries industry funding disclosed on the claim.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Observational cohorts link non-nutritive sweeteners to higher T2D/CVD risk, but bias-adjusted and substitution analyses neutralize or reverse this - it is largely reverse causality (metabolically-at-risk people adopt diet products). Replacing sugar with NNS is neutral-to-beneficial in trials. (Author groups carry industry-funding caveats.)
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ayoub-Charette S, Kavanagh M, Khan T, Sievenpiper J 2025 · Appl Physiol Nutr Metab | meta-analysis | contradicts | moderate | Umbrella review, units are syntheses not primary studies: 'we conducted an umbrella review of systematic reviews and meta-analyses ... We included six trial- and five cohort-based analyses.' Finding: 'In analyses of cohorts, LNCS was associated with higher obesity, diabetes, stroke, and cardiovascular and all-cause mortality in naïve analyses but lower body weight, waist circumference, obesity, coronary heart disease, and cardiovascular and all-cause mortality in bias-adjusted analyses.' GRADE 'generally moderate for trials and very low for cohorts.' Re-passes syntheses already counted; zero weight as review. Authors declare sweetener-industry honoraria (Calorie Control Council, International Sweeteners Association). Abstract-grade. |
| Serrano J, Smith KR, Crouch AL, Sharma V, Yi F, Vargova V, LaMoia TE, Dupont LM, Serna V, Tang F, Gomes-Dias L, Blakeslee JJ, Hatzakis E, Peterson SN, Anderson M, Pratley RE, Kyriazis GA 2021 · Microbiome | RCT | contradicts | moderate | High-dose saccharin did NOT disrupt human microbiome/glucose |
| Kim S, Song Y 2025 · Nutrition Journal (BMC Nutr J) | observational | mixed | low | Non-randomized crossover CGM study, n=66 healthy young Korean adults (mean age 22): 'This non-randomized crossover intervention study...consumed in a preference-based sequence' -- not an RCT (visit order was preference-based, not randomized). Zero cola (ASB, unspecified sucralose+acesulfame-K blend) added to a mixed meal did not raise iAUC180 vs muffin alone (113.3 vs 111.1 mmol·min/L; paired P=0.7832) -- no glycemic harm from ASB overall for most participants. But a classified subgroup (MZC-High responders, n=17 of 61 analyzed, after excluding ambiguous cases) showed a significantly HIGHER iAUC180 with muffin+zero cola than muffin+regular cola (150.2 vs 97.1 mmol·min/180min for MZC-Stable, P=0.0057) -- i.e. in ~28% of this cohort the 'diet' option produced a larger glycemic excursion than the sugared one when eaten with food. Genuinely mixed evidence on the glycemic-response pathway: null on average, a real minority harm signal, mechanism unexplained (authors speculate gut microbiota / taste-receptor signaling, untested here). |
| Azad MB, Abou-Setta AM, Chauhan BF, Rabbani R, Lys J, Copstein L, Mann A, Jeyaraman MM, Reid AE, Fiander M, MacKay DS, McGavock J, Wicklow B, Zarychanski R 2017 · CMAJ | meta-analysis | mixed | moderate | SR/meta-analysis: RCTs null for weight; cohorts linked routine NNS to higher weight, T2D and cardiovascular events. |
| Choi JH, Song S, Kim SK, Cho JW, Bae JH, Moon S, Lim JH, Lee Y, Hwang JY, Song Y, Kim SS 2026 · Diabetes Metab J | meta-analysis | contradicts | moderate | Own pooled data (14 RCTs, ASBs replacing SSBs) show no cardiometabolic harm: 'body weight was reduced by a mean of −0.73 kg (95% CI, −0.95 to −0.50)' (12 trials, 1,779 participants); HbA1c '−0.03% (95% CI, −0.11 to 0.05)' (3 RCTs); LDL '0.02 mmol/L; 95% CI, −0.07 to 0.11' (6 RCTs, n=800). The cohort half is an umbrella of 20 SRs ('we did not re-extract individual cohort data') reporting higher T2DM/CVD/mortality with ASBs — re-passed syntheses, not counted here. Comparator is SSB, not water. |
| Wang M, Wu OY, Wallen OG, Mozaffarian D 2026 · Curr Atheroscler Rep | meta-analysis | mixed | moderate | Narrative review plus meta-analysis: direct NNS physiological cardiometabolic effects limited; microbiome pathway uncertain. |
| López-Daza DF, Merchán-Chaverra R, Cuéllar-Fernández Y, Gómez-Univio MC, Ardila-Mendoza DB, Posada-Álvarez MC, Savino-Lloreda P 2025 · Nutr Hosp | meta-analysis | mixed | low | Critical commentary on the 2023 WHO NSS guideline: 'Observational research predominantly raises concerns about potential risks associated with NSS, but these studies face limitations, including biases and confounding variables that hinder causal conclusions.' No own data — review, zero weight. |
| Payen de la Garanderie M, Hasenbohler A, Dechamp N, Javaux G, Szabo de Edelenyi F, Agaësse C, De Sa A, Bourhis L, Porcher R, Pierre F, Coumoul X, Kesse-Guyot E, Allès B, Fezeu LK, Cosson E, Tatulashvili S, Huybrechts I, Hercberg S, Deschasaux-Tanguy M, Chassaing B, Rytter H, Srour B, Touvier M 2025 · PLoS Med | observational | mixed | moderate | NutriNet cohort: food-additive mixtures including sweeteners associated with higher type 2 diabetes incidence. |
| Tsai YJ, Fan HY, Hsu SY, Lin YF, Su CT, Lin HR, Chen YC 2025 · Clin Nutr | observational | mixed | low | Multicenter pediatric study: some non-nutritive sweeteners associated with elevated hypertension risk, effects varied. |
| Ayoub-Charette S 2026 · Appl Physiol Nutr Metab | meta-analysis | contradicts | moderate | Expert synthesis: RCTs show benefit when LNCS replace sugar; cohort harm signals reflect reverse causation/confounding. |
| Sun T, Yang J, Lei F, Huang X, Liu W, Zhang X, Lin L, Sun L, Xie X, Zhang XJ, Cai J, She ZG, Xu C, Li H 2024 · Cardiovasc Diabetol | observational | supports | moderate | UK Biobank: artificial-sweetener intake associated with higher incident CVD and mortality, partly mediated by T2D. |
| Harrold JA, Hill S, Radu C, Thomas P, Thorp P, Hardman CA, Christiansen P, Halford JCG 2024 · Int J Obes | RCT | contradicts | low | FT RCT: NNS beverages equivalent-to-better than water for weight loss; no cardiometabolic harm |
| Debras C, Deschasaux-Tanguy M, Chazelas E, Sellem L, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaësse C, De Sa A, Lutchia R, Julia C, Kesse-Guyot E, Allès B, Galan P, Hercberg S, Huybrechts I, Cosson E, Tatulashvili S, Srour B, Touvier M 2023 · Diabetes Care | observational | supports | moderate | NutriNet-Santé cohort: higher artificial-sweetener intake (aspartame) associated with increased type 2 diabetes risk. |
| Faeh D 2024 · Curr Opin Clin Nutr Metab Care | observational | mixed | moderate | Review: observational studies suggest harm but RCTs do not; likely reverse causation/confounding |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.